A phase I trial of EB 1020 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2012
At a glance
- Drugs Centanafadine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions; Therapeutic Use
- 18 Oct 2012 Status changed from recruiting to completed, as reported in a Neurovance media release.
- 22 Mar 2012 Results are expected by the end of 2012, according to a Euthymics media release.
- 22 Mar 2012 Status changed from not yet recruiting to recruiting, according to a Euthymics media release.